Hint mode is switched on Switch off

NeuroPace, ordinary share
NPCE, US6412881053

Add a stock to WL
Choose all Reset all
NeuroPace, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
NeuroPace, Inc. operates as a commercial-stage medical device company. The Company designs, develops, manufactures, and markets implantable devices for the treatment of neurological disorders with responsive stimulation. NeuroPace serves patients worldwide.
  • Issuer
  • Full borrower / issuer name
    NeuroPace, Inc.
  • Industry
    Medical Devices

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    NPCE
  • Placement
    22.04.2021
  • Lock up period
    180
  • Number of papers
    6,000,000
  • Volume of raised funds
    102 mln USD
  • Placement share
    26.17%
  • Final placement price
    17 USD
  • Price change since placement date
    -5.29%
  • By capitalization
    389.78 mln USD
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    NPCE
  • Placement
    18.02.2025
  • Lock up period
    180
  • Number of papers
    6,500,000
  • Volume of raised funds
    65 mln USD
  • Placement share
    17.92%
  • Final placement price
    10 USD
  • Price change since placement date
    61%
  • By capitalization
    362.78 mln USD

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
III q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
Show all Hide

Related Stock indices

Indicators

News

16/05/2026 NeuroPace (NASDAQ:NPCE) Q1 2026 Earnings: Strong Performance and Raised Guidance Drive Analyst Confidence
20/02/2026 NeuroPace to Report Fourth Quarter 2025 Financial Results on March 3, 2026
13/01/2026 NeuroPace Reports Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook
22/10/2025 NeuroPace to Report Third Quarter 2025 Financial Results on November 4, 2025
20/06/2025 NeuroPace: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Regulation Fd Disclosure, Financial Statements And Exhibits
All organization news

Holders

Industry Leaders

Registration is required to get access.